An Interview with Rami Lee, Chief Executive Officer of InBody Co. Ltd

Abstract

InBody is a South Korean success story that began as a startup venture to become a globally recognized leader in manufacturing of health care devices. This interview illustrates the reliance of the company on its cloud-supported information systems and technologies (IS/IT) to conduct its operations on a global scale. Our guest today is InBody’s Rami Lee (RL), who started her career in 2003 after earning her graduate degree in Public Health. Preiously, Rami was a director of InBoby Europe, where she proved her worth by contributing to 150% increase in sales in the region. JGITM: Please name your organization and briefly describe its business. RL: Being Korea’s top tech companies, InBody dominates the global market with locally developed technologies. Because we are able to successfully develop and commercialize our products, our overall growth rate is about 20%, and the exports account for about 80% of our revenues. One of our top-sellers is a body composition analyzer – a highly accurate and reliable state-of-the-art device based on the latest technologies for body composition analysis. This is not an exception for InBody, but a norm, because all of our products are based on new medical technologies. We feel that we deliver a great value to our customers, and we are working hard to expand our business. In order to grow, we are using our offices in major countries as forward bases – this allows us to introduce our products and make inroads in new markets.